Trial
NCT01370694
Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Merck Sharp & Dohme LLC
Collaborators
—
Condition
Follicular Lymphoma
Intervention
MK-8808
Why stopped
The study was terminated for business reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-15